Human primary retinal pigment epithelial (hurpe) cells    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1

90. Retinitis pigmentosa    [ 103 clinical trials,   158 drugs,   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways]
Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 103 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03566147
(ClinicalTrials.gov)
August 1, 201812/6/2018Treatment of RP and LCA by Primary RPE TransplantationTreatment of Retinitis Pigmentosa and Leber Congenital Amaurosis by Primary Retinal Pigment Epithelial Cells TransplantationLeber Congenital Amaurosis, Retinitis PigmentosaBiological: Human primary Retinal Pigment Epithelial (HuRPE) cellsEyecure Therapeutics Inc.Beijing Tongren HospitalUnknown status18 Years70 YearsAll30Early Phase 1China